Abstract
Organometallic chemistry has long played an important role in the synthesis of structurally unique and complex bioorganic compounds; however, it has been only within the last decade that the principles developed for synthetic organic chemistry have been applied to radiopharmaceutical chemistry. Since 1978 one can observe, in addition to the organotin reagents, the use of organolithium and Grignard reagents [3–4], organoboranes [5–8], organomercurials [9–11], and organosilanes [12–16] in the preparation of radio-chemicals. Although each of these reagents possesses certain methodological advantages, none can be applied to synthesis of all classes of compounds nor to the incorporation of all radionuclides. Organostannanes, organoboranes and organosilanes share many similar features with respect to the types of radionuclides that can be introduced and the classes of compounds which are accessible to radioisotope incorporation. However, it is the special features associated with the organostannanes that have made them of particular interest to us in our radiopharmaceutical chemistry program.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
C. Halldin and B. Langstrom. Acta. Chem. Sc. and Ser. B. 38 (1984): 1–4.
A Rimland and B. Langstrom. Appl. Radiat. Isot. 38 (1987): 949–951.
G.W. Kabalka. Acc. Chem. Res. 77 (1984): 215–221.
G.W. Kabalka. Aldrichimic Acta. 19 (1986): 11–16.
G.W. Kabalka. In: “Synthesis and Applications of Isotopically Labelled Compounds, 1985.” T.R. Baillie and J.R. Jones, eds., Elsevier Science Publishers, B.V., Amsterdam, 1986.
G.W. Kabalka. In: “Synthesis and Application of Isotopically Labelled Compounds, 1988.” T.R. Baillie and J.R. Jones, eds., Elsevier Science Publishers, B.V., Amsterdam, 1989.
F.O. Charleson, R.J. Flanagan, E.J. Synnes, and L.I. Wiebe. J. Labelled. Comp. Radiopharm. 21 (1984): 1007–1008.
R.J. Flanagan, F.P. Charleson, E.I. Synnes, Y.X. Theriault and T.T. Nakashima. Can. J. Chem. 63 (1985): 2853–2860.
R.J. Flanagan. In: “Synthesis and Applications of Isotopically Labelled Compounds, 1988.” T.R. Baillie and J.R. Jones, eds., Elsevier Science Publishers, B.V., Amsterdam, 1989.
D.S. Wilbur and S.Z. Svitra. J. Labelled. Comp. Radiopharm. 21 (1984): 415–428.
D.S. Wilbur, K.W. Anderson, W.E. Stone and H.A. O’Brien, Jr. J. Labelled. Comp. Radiopharm. 19 (1982): 1171–1188.
D.S. Wilbur, W.E. Stone and K.W. Anderson. J. Org. Chem. 48 (1983): 1542–1544.
S.R. Wilson, L.A. Jacob. J. Org. Chem. 51 (1986): 4833–4836.
D.S. Wilbur, S.R. Garcia, M.J. Adams and T.J. Ruth. J. Labelled. Comp. Radiopharm. 21 (1984): 767–779.
D.E. Seitz, G.L. Tonnesen, S. Hellman, R.N. Hanson and S.J. Adelstein. J. Organomet. Chem. 186 (1980): C33 - C36.
G.L. Tonnesen, R.N. Hanson and D.E. Seitz. Int. J. Appl. Radiat. Isot. 32 (1980): 171–173.
J.A. Katzenellenbogen, K.E. Carlson, D.F. Heiman and J.E. Lloyd. In: “Radiopharmaceuticals: Structure-Activity Relationships.” R.P. Spencer, ed., Grine and Stratton, New York (1981), 23–86.
J.A. Katzenellenbogen, D.F. Heiman, K.E. Carlson and J.E. Lloyd. In: “Receptor Binding Productions.” W.C. Eckelman, ed. CRC Press, Boca Raton, FL (1983), 93–126.
C.C. Huang and A.M. Friedman. In: “Radiotracers for Medical Applications, Vol. I.” G.V.S. Rayudu, ed. CRC Press, Boca Raton, FL (1983), 219–261.
R.M. Baldwin. Appl. Radiat. Isot. 37 (1986): 817–821.
R.E. Counsell and N. Korn. In: “Principles of Radiopharmacology, Vol. I.” L.G. Colombetti, ed. CRC Press, Boca Raton, FL (1979), 189–250.
R.N. Hanson. In: “New Methods in Drug Research, Vol. 2.” A. Makriyannis, ed. J.R. Prons, Barcelona, Spain (1988), 78–114.
M.E. Jung and L.A. Light. Tet. Letters 23 (1982): 3851–3854.
G.A. Tolstikov, M.S. Miftakhov, N.A. Danilova and Ya. L. Vel’der. Synthesis (1986), 496–499.
A.J. Leusink, H.A. Budding and J.W. Marsman. J. Organomet. Chem. 9 (1967): 285–294.
E.J. Corey, P. Ulrich and J.M. Fitzpatrick. J. Amer. Chem. Soc. 98 (1976): 222–224.
P.W. Collins, C.J. Jung, A. Gosienki and R. Pappo. Tet. Letters (1978), 3187–3190.
C. Nativi and M. Tadde. J. Org. Chem. 53 (1988): 820–826.
K. Nozaki, K. Oshima and K. Utimoto. J. Amer. Chem. Soc. 109 (1987): 2547–2549.
J.R. Behling, J.S. Ng, K.A. Babiak and A.L. Campbell. Tet. Letters 30 (1989): 27–30.
J.C. Bottaro, R.N.Hanson and D. E. Seitz. J. Org. Chem. 46 (1981): 5221–5222.
R.N. Hanson and D.E. Seitz. Trans. Am. Nucl. Soc. 39 (1981): 32–33.
R.N. Hanson and D.E. Seitz. Proc. of the Third World Congress of Nuclear Medicine and Biology. Vol. III. Paris (1982), 3200–3203.
J.R. Behlinger, K.A. Babiak, J.S. Ng, A.L. Campbell, R. Moretti, M. Koernergard, B.H. Lipshutz. J. Amer. Chem. Soc. 110 (1988): 2641–2643.
J.K. Stille. Angew. Chem. Int. Ed. Engl. 25 (1986): 508–524.
J.K. Stille and B.L. Groh. J. Amer. Chem. Soc. 109 (1987): 813–817.
W.J. Scott and J.E. McMurray. Asc. Chem. Res. 21 (1988): 47–54.
M. Shibasaki, Y. Torisawa and S. Ikegami. Tet. Lett. 23 (1982): 4607–4610.
M. Ratier, D. Khatmi, J.G. Duboudin and D.T. Minh. Synth. Commun. 19 (1989): 285–291.
W.F. Goure, M.E. Wright, P.D. Davis, S.S. Labadie and J.K. Stille. J. Amer. Chem. Soc. 106 (1984): 6417–6422.
J.G.M. Vanderkerk and J.G. Noltes. J. Appl. Chem. 9 (1959): 179–185.
R.N. Hanson and H. El Wakil. J. Org. Chem. 52 (1987): 3687–3688.
D.M. Wieland, J.-C. Wu, L.E. Brown, T.J. Mangner, D.P. Swanson and W.H. Beierwaltes. J. Nucl. Med. 21 (1980): 349–353.
J. Mertens, W. van Ryckeghem and A. Bossuyt. J. Labelled. Comp. Radiopharm. 22 (1985): 89–93.
M.J. Adam, T.J. Ruth, S. Jivan and B.D. Pate. J. Fluorine Chem. 25 (1984): 329–337.
S.M. Moerlein. J. Org. Chem. 52 (1987): 664–667.
K.R. Wursthorn and H.G. Kuivila. J. Org. Chem. 140 (1977): 29–39.
G. Kloster, P. Laufer and J. Hanus. J. Labelled Comp. Radiopharm. 22 (1985): 397–404.
S. Moerlein and G. Stocklin. J. Med. Chem. 28 (1985): 1319–1324.
T.R. Kelly, C. Zhao and G.J. Bridger. J. Amer. Chem. Soc. 111 (1989): 3744–3745.
M.J. Sharp and V. Snieckus. Tet. Letters. 26 (1985): 5997–6000.
D.E. Seitz, S.-H. Lee, R.N. Hanson and J.C. Bottaro. Synth. Commun. 13 (1983): 122–129.
S.-H. Lee, R.N. Hanson and D.E. Seitz. Tet. Lett. 25 (1984): 1751–1752.
L. Franke, R.N. Hanson, S.-H. Lee, M. Kaplan and D.E. Seitz. J. Nucl. Med. 24 (1983): P 116.
R.N. Hanson, L. Franke, S.-H. Lee and D.E. Seitz. Appl. Radiat. Isot. 38 (1987): 641–645.
B. Jousseaume. J.C.S. Chem. Commun. (1984), 1452–1453.
G.L. Tonnesen, R.N. Hanson and D.E. Seitz. Int. J. Appl. Radiat. Isot. 32 (1981): 171–173.
R.N. Hanson, D.E. Seitz and G.L. Tonnesen. J. Labelled Comp. Radiopharm. 18 (1981): 99–100.
R.N. Hanson, G.L. Tonnesen, W.H. McLaughlin, W.D. Bloomer and D.E. Seitz. J. Labelled Comp. Radiopharm. 18 (1981): 128–129.
M.J. Adam, B.D. Pate, T.J. Ruth, J.M. Berry and L.D. Hall. J. Chem. Soc. Chem. Commun. (1981), 733.
M.J. Adam, T.J. Ruth, B.D. Pate and L.D. Hall. J. Chem. Soc. Chem. Commun. (1982), 625–626.
M.J. Adam, J.M. Berry, L.D. Hall, B.D. Pate and T.J. Ruth. Can. J. Chem. 61 (1983): 658–660.
M.J. Adam. T.J. Ruth, Y. Hamma and B.D. Pate. Int. J. Appl. Radiat. Isot. 36 (1985): 935–937.
M.J. Adam. Appl. Radiat. Isot. 37 (1986): 811–815.
S.M. Moerlein. J. Chem. Soc. Perkin. Trans. I. (1985), 1687–1692.
S.M. Moerlein and H.H. Coenen. J. Chem. Soc. Perkin. Trans. I. (1985), 1941–1947.
S.M. Moerlein, C.A. Mathis and Y. Yano. Appl. Radiat. Isot. 38 (1987): 85–90.
S.M. Moerlein, W. Beyer and G. Stocklin. J. Chem. Soc. Perkin. Trans. I. (1988), 779–786.
J.-P. Raynaud, T. Ojasso, M.M. Bouton and D. Philibert. In: “Drug Design, VII.” E.J. Ariens, ed. Academic Press, NY (1979), 169–214.
L. Terenius. Acta. Endocrin. 66 (1971): 431–447.
B.G. James, G. Pattenden and L. Barlow. J. Chem. Soc. Perkin. Trans. I. (1976), 1466–1475.
R.N. Hanson, D.E. Seitz and J.C. Bottaro. J. Nucl. Med. 23 (1982): 431–436.
R.N. Hanson, D.E. Seitz and J.C. Bottaro. Int. J. Appl. Radiat Isot. 35 (1984): 810–812.
L.A. Franke and R.N. Hanson. J. Nucl. Med. 25 (1984): 1116–1121.
R.N. Hanson, L.A. Franke and M.L. Kaplan. J. Labelled Comp. Radiopharm. 21 (1984): 1172–1173.
R.N. Hanson, L.A. Franke and M. Kaplan. J. Nucl. Med. 27 (1986): 939.
R.N. Hanson, L.A. Franke and M. Kaplan. Nucl. Med. Biol. 16 (1989): 3–9.
R.N. Hanson, H. El-Wakil, F. Murphy and D.S. Wilbur. J. Labelled. Comp. Radiopharm. 27 (1989): 615–627.
R.N. Hanson, L.A. Franke and M. Kaplan. Nucl. Med. Biol. 17 (1990): 239–245.
J.A. Balatano, M.J. Adams and D. Hall. J. Nucl. Med. 22 (1986): 972.
K.M.R. Pillai, W.H. McLaughlin, R.M. Lambrecht and W.D. Bloome. J. Labelled Comp. Radiopharm. 24 (1987): 1117–1122.
E.R. DeSombre, R.C. Mease, A. Hughes, P.V. Harper, O.T. DeJesus and A.M. Friedman. Cancer Res. 48 (1988): 899–906.
S.J. Gatley, E.R. DeSombre, A. Hughes, M.-L. Pan and B. Teaster. J. Nucl. Med. 30 (1989): 924.
R. Atcher, M. Pan, S.J. Gatley, G. Peterson and E.R. DeSombre. J. Nucl. Med. 60 (1989): 925.
M.V. Merrick, J.E.T. Corrie, A.M. Millar and R.A. Hawkins. Nucl. Med. Biol. 15 (1988): 327–332.
H. Ali, J. Rousseau, M.A. Ghaffari and J.E. van Lier. J. Med. Chem. 31 (1988): 1946–1950.
R.N. Hanson, E. Napolitano, R.Faschi and D.R. Elmaleh. Unpublished results.
R.C. Mease, E.R. DeSombre, A. Hughes, A.M. Friedman and R.H. Seevers. J. Nucl. Med. 27 (1980): 972.
R.C. Mease, E.R. DeSombre, A. Hughes, P. Harper, O.T. DeJesus. J. Nucl. Med. 28 (1987): 572.
R.H. Seevers, R.C. Mease, A.M. Friedman and E.R. DeSombre. Nucl. Med. Biol. 13 (1986): 483–495.
E.R. DeSombre, R.C. Mease, J. Sanghavi, T. Singh, R.H. Seevers and A. Hughes. J. Steroid Biochem. 29 (1988): 583–590.
E.R. DeSombre, P.V. Harper, A. Hughes, R.C. Mease, S.J. Gatley, O.T. DeJesus and J.L. Schwartz. Cancer Res. 48 (1988): 5805–5809.
R.A. Milius, W.H. McLaughlin, R.M. Lambrecht and A.P. Wolf. Int. J. Appl. Radiat. Isot. 37 (1986): 799–802.
D.E. Seitz and L.C. Blaszczak. Synth. Commun. 18 (1988): 2353–2357.
F.G. Salituro, K.E. Carlson, J.F. Ellison, B.S. Katzenellenbogen and J.A. Katzenellenbogen. Steroids. 48 (1986): 287–313.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hanson, R.N. (1991). Radioisotope Incorporation Via Aryl and Alkenyl Trialkyltin Intermediates. In: Emran, A.M. (eds) New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0626-7_28
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0626-7_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0628-1
Online ISBN: 978-1-4899-0626-7
eBook Packages: Springer Book Archive